Groupe de recherche en écologie buccale
(GREB), Département de biochimie et de microbiologie,
Faculté des sciences et de génie, and Faculté de
médecine dentaire, Université Laval, Québec, Canada
G1K 7P4
In streptococci, HPr, a phosphocarrier of the
phosphoenolpyruvate:sugar phosphotransferase transport system (PTS),
undergoes multiple posttranslational chemical modifications resulting
in the formation of HPr(His~P), HPr(Ser-P), and HPr(Ser-P)(His~P), whose cellular concentrations vary with growth conditions. Distinct physiological functions are associated with specific forms of HPr. We
do not know, however, the cellular thresholds below which these forms
become unable to fulfill their functions and to what extent
modifications in the cellular concentrations of the different forms of
HPr modify cellular physiology. In this study, we present a glimpse of
the diversity of Streptococcus salivarius ptsH mutants that
can be isolated by positive selection on a solid medium containing 2-deoxyglucose and galactose and identify 13 amino acids that are
essential for HPr to properly accomplish its physiological functions.
We also report the characterization of two S. salivarius mutants that produced approximately two- and threefoldless HPr and
enzyme I (EI) respectively. The data indicated that (i) a reduction in the synthesis of HPr due to a mutation in the
Shine-Dalgarno sequence of ptsH reduced ptsI
expression; (ii) a threefold reduction in EI and HPr cellular levels
did not affect PTS transport capacity; (iii) a twofold reduction in HPr
synthesis was sufficient to reduce the rate at which cells metabolized
PTS sugars, increase generation times on PTS sugars and to a lesser
extent on non-PTS sugars, and impede the exclusion of non-PTS sugars by
PTS sugars; (iv) a threefold reduction in HPr synthesis caused a strong
derepression of the genes coding for
-galactosidase,
-galactosidase, and galactokinase when the cells were grown at the
expense of a PTS sugar but did not affect the synthesis of
-galactosidase when cells were grown at the expense of lactose, a
noninducing non-PTS sugar; and (v) no correlation was found between the
magnitude of enzyme derepression and the cellular levels of HPr(Ser-P).
 |
INTRODUCTION |
Histidine-containing
protein, heat-stable protein, and heteromorphous protein are all
epithets that have been used to designate HPr, the bacterial
phosphocarrier of the phosphoenolpyruvate:sugar phosphotransferase
transport system (PTS) (19, 41). Results obtained
over the past decade unequivocally indicate that the qualifier
"heterofunctional protein" also applies to this small, approximately 9-kDa protein (27, 31, 35).
The PTS is a multienzyme complex that sequentially catalyzes the
transport and phosphorylation of sugars (27, 32) and plays
a cardinal role in regulatory processes that allow bacteria to
metabolize sugars differently depending on environmental conditions (31, 33, 35, 45). The HPr of gram-positive bacteria can be
phosphorylated on His15 at the expense of phosphoenolpyruvate by enzyme
I (EI) of the PTS and on Ser46 by the ATP-dependent HPr(Ser)
kinase-phosphatase (HPrK) (27, 31, 33, 35, 45). HPr(His~P) not only is involved in sugar transport but also controls transcription of several genes by transferring its phosphate group to
histidine residues of antiterminators and transcriptional activators with PTS regulation domains (34). HPr(His~P) also
controls glycerol kinase of Enterococcus faecalis and
Enterococcus casseliflavus (4, 5) and the
lactose permease of Streptococcus thermophilus, and possibly
of Lactobacillus bulgaricus, Pediococcus
pentosoceus, and Leuconostoc lactis, by reversible
phosphorylation (25, 26, 47). HPr(Ser-P) is not involved
in sugar transport. However, this form of HPr controls transcription of
catabolic genes in conjunction with a DNA-binding protein called CcpA
that recognizes a specific DNA sequence called CRE
(catabolite-responsive element) located in the promoter region of
target operons. In Bacillus subtilis, the association of
CcpA with a number of CRE sequences is promoted by HPr(Ser-P) (6,
8, 13, 17) and results in the activation or inhibition of gene
transcription depending on whether the CRE sequence is located upstream
or downstream from the promoter sequence (16, 35).
HPr(Ser-P) also allosterically controls the activity of sugar permeases
in lactococci, lactobacilli, enterococci, and streptococci (7,
48, 50-52).
To properly accomplish their diverse functions, the different forms of
HPr must be synthesized at the appropriate concentrations. Previous
work has already demonstrated that cellular levels of HPr in
streptococci vary two- to threefold with culture conditions and that
the relative proportions of the different forms of HPr also change with
respect to growth rate (14, 36, 43, 44). However, we do
not know to what extent these variations alter the capacity of HPr to
fulfill its functions.
To shed more light on the relationship between cellular concentrations
of HPr and its physiological functions, we sought to characterize
mutants producing lower levels of HPr than that of the wild-type
strain. In a previous study conducted with Streptococcus salivarius ATCC 25975, we observed that several types of PTS
mutants, including ptsH mutants, could be obtained by
positive selection on 2-deoxyglucose (2DG) in the presence of various
metabolizable sugars (11). Preliminary data
suggested that selection in the presence of galactose favored the
isolation of ptsH mutants. We thus decided to verify whether
selection in the presence of 2DG and galactose engendered a bias toward
the isolation of ptsH mutants and, if so, to use this
approach to isolate mutants producing lower levels of HPr. In this
paper, we present a glimpse of the diversity of ptsH mutants
that can be isolated by plating S. salivarius on a solid
medium containing 2DG and galactose and report the characterization of
two S. salivarius mutants that synthesize approximately two-
and threefold less HPr and EI.
 |
MATERIALS AND METHODS |
Strains and growth conditions.
S. salivarius ATCC
25975 was kindly provided by I. R. Hamilton (University of
Manitoba). ptsH mutants were isolated by positive selection
for resistance to 5 mM 2DG in the presence of 200 mM galactose. Cells
were grown at 37°C in a medium containing 10 g of tryptone and
5 g of yeast extract (Difco Laboratories), 2.5 g of NaCl, and
2.5 g of disodium phosphate per liter. Sugars were sterilized by
filtration (Millipore filter, 0.22-µm pore size) and added
aseptically to the medium to give the appropriate concentrations. When
the parental strain was grown in this medium without sugar, the culture
reached a maximum optical density at 660 nm (OD660) of
approximately 0.1. Generation times were determined by growing the
cells at 37°C in the presence of 0.1% (wt/vol) sugar in tubes (16 by
125 mm) containing 10 ml of medium. The tubes were inoculated with 0.1 ml of an overnight culture grown in the presence of 0.1% sugar. Growth
was monitored by monitoring the OD660. For growth studies
in media containing two sugars, the bacteria were grown in tubes
containing 15 ml of medium supplemented with 0.1% glucose or fructose
(PTS sugar) and 0.2% lactose or galactose (non-PTS sugar). For some
studies, the cells were grown in the presence of 0.2% lactose or
galactose, and when the OD660 reached approximately 0.35, glucose or fructose was added to a final concentration of 0.1%.
Samples (0.25 to 0.5 ml) were taken at intervals, heated at 100°C for
10 min to stop metabolism, centrifuged to remove cells, and then stored
at
20°C for sugar assays.
Identification of ptsH mutants.
Clones were
grown in 3 ml of culture medium containing 5 mM 2DG and 0.5%
galactose. When the OD660 reached 0.45, the cells were
harvested by centrifugation and resuspended in 150 µl of a solution
containing 125 mM Tris-HCI (pH 6.8), 10% (vol/vol) glycerol, 10%
(wt/vol) Nonidet P-40, and 0.7 µM
-mercaptoethanol. They were then
lysed with a Sonifier cell disrupter using the pulse mode (15 pulses)
at energy level 5 (model W-350; Branson Sonic Power Co.). During the
sonication treatment, the recipient containing the cell suspension was
kept on ice. The extract was incubated at 100°C for 5 min, and the
proteins were separated by polyacrylamide gel electrophoresis under
native conditions with separating gels containing 12.5% acrylamide as
described by Robitaille et al. (29). The position of HPr
in the gel was determined by Western blotting as described by
Robitaille et al. (29) using specific anti-HPr rabbit
polyclonal antibodies. Presumptive HPr mutants were selected by
comparing their HPr electrophoretic patterns with that of the wild-type
strain on the basis of two criteria: the intensity and electrophoretic
mobility of the proteins that reacted positively with the anti-HPr antibodies.
HPr and EI determinations.
The cytoplasmic fraction was
prepared as described previously (24), and the
quantification of the cellular forms of HPr was carried out by crossed
immunoelectrophoresis as already reported (43). A standard
curve was obtained using purified S. salivarius HPr. Since
the classic techniques used to determine protein concentrations gave
erroneous results with HPr, we determined its concentration in purified
preparations by amino acid analysis following acid hydrolysis. The
protein concentration of a purified preparation of HPr measured in this
way was two- to sixfold lower than that determined by the methods of
Lowry and Bradford. The amount of EI was determined by rocket
immunoelectrophoresis using specific rabbit polyclonal antibodies
obtained against purified EI as described previously (10),
except that Tris-Tricine was replaced by Tris-barbiturate. A standard
curve was obtained using purified S. salivarius EI.
Sequencing of ptsH, ptsI, and hprK.
The nucleotide sequences of the ptsH and ptsI
genes were determined as described by Gauthier et al.
(11). The sequence of the region upstream from the
35
box of the pts promoter was obtained after amplification of
a 398-bp DNA fragment by PCR using two oligonucleotides
(5'-TATCTTTACAGCTGACTTAG-3' and
5'-GCTGGACGTGCGTGGAT-3') that annealed with a region of the
idh gene located 252 bp upstream from the
35 region of the
pts promoter and with a region in the ptsH gene.
The nucleotide sequence of the hprK gene that codes for the
HPrK was determined after amplification of a 2,040-bp DNA fragment by
PCR using two oligonucleotides (5'-ATGATTGGCCCTGGTGCTA-3' and 5'-ACCACATGACGGGTACGAAG-3') that annealed 103 nucleotides upstream and 1,917 nucleotides downstream from the
initiation codon of hprK, respectively. The following
primers were used to determine the sequences on both strands of the
hprK gene and its promoter region:
5'-TATGATTGGCCCTGGTGCTA-3', 5'-GGTAAGAGTGAAACAGGG-3', and 5'-CCAAGACGATCAAGACC-3'. The PCR was performed
using a DNA Thermal Cycler 480 (Perkin-Elmer) in a total volume of 100 µl containing 50 mM KCl, 10 mM Tris-HCl (pH 8.3), 1.5 mM
MgCl2, 0.2 µM forward and reverse primers, and 200 µM
(each) four deoxynucleotide triphosphates. The mixtures were incubated
at 94°C for 5 min prior to the addition of 2.5 U of Taq
DNA polymerase (Perkin-Elmer). The reactions were carried out for 25 cycles with the following temperature profile: 94°C for 90 50°C for
60 and 72°C for 2 min. All cycles were performed with an
autoextension cycle that adds 5 per cycle to the third step of the
temperature profile. At the end of the amplification process, the
samples were incubated for 10 min at 72°C. The amplicons were
purified using a Gene Clean Spin kit (Bio 101). The PCR was carried out
with DNA extracted by suspending bacterial colonies into 100 µl of
distilled water and placing the samples in boiling water for 1 min
(21).
Uptake experiments and glucose consumption by resting cells.
The uptake of [14C]2DG was performed with cells grown in
0.2% glucose and harvested at mid-log phase. Uptake was carried out at
10°C in 50 mM potassium phosphate buffer (pH 7.0) as described previously (46). Glucose consumption by resting cells was
carried out as followed. Cells were grown in the presence of 0.2%
glucose, and growth was stopped by the addition of chloramphenicol (50 µg ml
1). The cells were harvested by centrifugation,
washed twice with 10 mM MgSO4, and resuspended in 100 mM
sodium phosphate (pH 7.0) at 20 mg (wet weight) per ml. The cell
suspension (10 ml) was maintained at 37°C and gently mixed on a
magnetic stirrer. Glucose was added to a final concentration of 0.2%,
and the pH was maintained by automatic titration with 0.3 N NaOH.
Enzyme assays.
Cells were grown in 500 ml of medium
containing 0.2% sugar. Chloramphenicol (50 µg per ml) was added to
stop cell growth in the exponential phase. For measurement of HPrK
activities, the cellular extracts were prepared by sonication as
described by Brochu and Vadeboncoeur (2). For the other
enzymes, the cells were harvested by centrifugation, washed once with
50 mM potassium phosphate (pH 7.0) containing 5 mM
-mercaptoethanol,
and then frozen at
40°C. The cells were disrupted by grinding with
alumina in the presence of 0.1 mM phenylmethylsulfonyl fluoride and 1 µM pepstatin A as previously described (40). The broken
cell suspensions were centrifuged first at 3,000 × g
for 5 min at 4°C to remove intact cells and alumina and then at
16,000 × g for 20 min to remove cell debris. The
supernatant (cellular extract) was then dialyzed at 4°C for 20 h
against 10 mM sodium phosphate (pH 7.0) and used to assay enzyme
activities.
-Galactosidase activity was assayed using
O-nitrophenyl-
-galactopyranoside (ONPG) as the substrate
(15).
-Galactosidase activity was assayed using
p-nitrophenyl-
-galactopyranoside as the substrate
(22). Galactokinase activity was assayed by measuring the
rate of phosphorylation of [14C]galactose at the expense
of ATP as described previously (42). HPrK activities were
measured with [
-32P]ATP and purified HPr from S. salivarius as described previously (2). In all cases,
enzyme assays were performed under conditions where the rate of
reaction was kept constant with the time of incubation and proportional
to the enzyme concentration.
Sugar assays.
The glucose concentration was measured using a
peroxidase-glucose oxidase assay (Sigma). Lactose was assayed in the
presence of glucose or fructose by measuring the concentration of
glucose or galactose in samples before and after hydrolysis with
-galactosidase for 1 h at 37°C in 233 mM citrate buffer (pH
6.6) containing 60 mM MgSO4 and 0.05 U of
-galactosidase
(Worthington) per µl. Galactose was determined using a
peroxidase-galactose oxidase assay (1). Fructose was
measured by the resorcinol method (30).
Protein assay.
Protein concentrations were measured using
the method of Peterson (23) with bovine serum albumin as
the standard.
 |
RESULTS |
Isolation of ptsH mutants.
In a previous study, we
reported that several types of PTS-negative mutants could be isolated
by plating S. salivarius on a medium containing 2DG and a
metabolizable sugar (11). We observed that the frequency
at which mutants could be isolated was highest with the combination 2DG
and galactose and that selection on galactose seemed to favor the
isolation of ptsH mutants. To determine whether selection on
this combination of sugars actually results in a bias toward the
isolation of ptsH mutants, we decided to repeat the
experiment on a larger scale by analyzing 546 mutants obtained by
plating S. salivarius on a solid medium containing 2DG and galactose. To rapidly detect ptsH mutants, the HPr of the
selected clones was analyzed by polyacrylamide gel electrophoresis and Western blotting as described in Materials and Methods. A typical wild-type HPr electrophoretic pattern obtained using this procedure is
shown in lane 1 of Fig. 1. We observed
that approximately 50% of the clones that we analyzed exhibited
several distinctive aberrant HPr electrophoretic mobility patterns.
Some examples are shown in Fig. 1. DNA sequencing analysis of these
clones confirmed that they were mutated in ptsH. The
spectrum of ptsH mutations obtained with this approach is
summarized in Table 1. A consensus amino acid sequence for gram-positive bacterial HPrs was deduced from a
sequence comparison of 19 HPrs from gram-positive bacteria (Fig. 2). With the exception of the H7
L
substitution and the A70
T substitution, we observed that all of the
ptsH mutations conferring resistance to 2DG resulted in the
substitution of a conserved residue. The mutations occurred mainly in
the region of
-helix 1 and in the N-terminal regions of
-helices
2 and 3.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 1.
Electrophoretic patterns of wild-type HPr and of
selected HPr mutants. Cells were lysed by sonication, and the resulting
cellular extracts were incubated at 100°C for 5 min. The proteins
were then separated by polyacrylamide gel electrophoresis under native
conditions. The position of HPr in the gel was determined by Western
blotting using anti-HPr-specific rabbit polyclonal antibodies.
Wild-type free HPr migrated as a doublet since a portion of the HPr is
not processed by the methionine aminopeptidase. This phenomenon results
in a population of HPr consisting of two forms; HPr-1 (without Met) and
HPr-2 (with Met) (29, 41). Because the cellular extract
was heated before electrophoresis, HPr(His~P) and the doubly
phosphorylated product could not be observed. Lane 1, pattern of the
wild-type strain; lane 2, example of pattern observed with mutants with
mutations in the promoter or the 5' UTR of the pts operon;
lanes 3 to 6, examples of aberrant patterns observed with mutants with
point mutations in ptsH. "Ga" indicates strain
designations.
|
|

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 2.
Locations of substituted amino acids in ptsH
mutants selected in the presence of 5 mM 2DG and 200 mM galactose. The
first row indicates the secondary structures common to HPrs from
gram-positive bacteria: S, -strand; H, -helix. The second row
shows the consensus amino acid sequence of HPrs from gram-positive
bacteria deduced from a multiple alignment analysis of the amino acid
sequences of 19 HPrs from the following bacteria: Staphylococcus
carnosus, Staphylococcus aureus, Staphylococcus
epidermidis, Listeria monocytogenes, S. mutans, Streptococcus bovis, Streptococcus
pyogenes, S. salivarius, Streptococcus
pneumoniae, Streptococcus equi, Lactococcus
lactis, Lactobacillus casei, Lactobacillus
sake, E. faecalis, B. subtilis,
Bacillus megaterium, Bacillus stearothermophilus,
Bacillus halodurans, and Clostridium acetobutylicum.
Uppercase indicates that the amino acid is conserved in all sequences,
whereas lowercase indicates that it is conserved in at least 15 out of
19 sequences. The third row shows the amino acid sequence of S. salivarius HPr. The fourth row indicates the location and nature
of the substitution in S. salivarius ptsH mutants isolated
in the presence of 2DG and galactose.
|
|
Some mutants that were isolated in the presence of 2DG and galactose
exhibited an HPr electrophoretic pattern similar to that of the
parental strain but contained much less HPr, suggesting that they bore
a mutation that reduced HPr synthesis (Fig. 1, lane 2). In S. salivarius, the genes coding for HPr and EI, designated ptsH and ptsI, respectively, form the
pts operon. Transcription of the pts operon is
initiated from a single promoter located upstream from ptsH
(9). The promoter consists of conserved
35 and
10
boxes separated by 17 nucleotides and followed by a 5' untranslated
region (5' UTR) of 54 nucleotides comprising the ptsH
ribosome binding site (Fig. 3). DNA
sequence analysis of mutants possessing lower amounts of HPr revealed
that they all possessed mutations in these regions (Table 1). Two
mutants were selected for further study: Ga 2.45 had a point mutation in the
35 sequence substituting a T for a C at position
36, while
mutant Ga 1.13 had a point mutation in the Shine-Dalgarno sequence of
ptsH substituting an A for a G at position +45 (Fig. 3). No
other mutations were detected in the pts operons of these mutants, nor in the 252-bp region upstream from the
35 box of the
pts promoter.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 3.
Nucleotide sequence of the 5' end of the S. salivarius pts operon. The following DNA signal sequences are
underlined: the 35 and 10 boxes of the promoter, the
transcriptional start point (+1), the ribosome binding sites (SD) of
ptsH and ptsI, and the start codons of
ptsH and ptsI. Mutations in Ga 2.45 and Ga 1.13 are indicated in boldface.
|
|
Cellular levels of HPr and EI.
The intracellular levels of the
different forms of HPr were determined in glucose- and fructose-grown
cells harvested at mid-log phase (Table
2). As already reported (12,
43), rapidly growing wild-type cells contained mostly HPr(Ser-P)
and the doubly phosphorylated product HPr(Ser-P)(His~P) and very low
levels of HPr(His~P) and unphosphorylated HPr. Total HPr was
approximately two fold lower in Ga 1.13 and about threefold lower in Ga
2.45. The mutations not only decreased the total amount of HPr but also
changed the levels of the different forms of HPr in the cells. The main
changes were a 2- to 4-fold decrease in the level of HPr(Ser-P) and a 1.4- to 6-fold decrease in the level of the doubly phosphorylated product. To determine whether the decrease observed in the levels of
HPr(Ser-P) could result from a diminution in the activity of HPrK, we
sequenced hprK from both mutants and measured HPrK
activities in glucose-grown wild-type and mutant cells. No mutation was
detected in hprK and in hprK promoter regions of
both mutants. The HPrK activities, determined on two separate cultures
and expressed as picomoles HPr(Ser-P) produced per microgram of protein
per minute were 2.0 ± 0.2 for the wild-type strain, 2.3 ± 0.7 for mutant Ga 1.13, and 2.0 ± 0.4 for mutant Ga 2.45. These
results indicated that the drop in the cellular levels of HPr(Ser-P) in Ga 1.13 and Ga 2.45 could not be attributed to a decrease in the synthesis or the activity of HPrK.
The mutation in the
35 promoter region (Ga 2.45) caused a three fold
decrease in the amount of EI, irrespective of the culture conditions
tested, a decrease that paralleled the decline in total HPr. The
mutation in the ribosome binding site of ptsH was expected to reduce the levels of HPr but not that of EI. Surprisingly, we
observed that the level of EI was reduced about twofold in this mutant.
Generation times.
The generation times of the wild-type and
mutant strains were determined for cells growing at the expense of
either 0.1% (wt/vol) glucose or fructose, each a PTS sugar, or
galactose or lactose, each a non-PTS sugar (Table
3). The wild type grew at virtually the
same rate on all the sugars tested. The growth of the mutants on PTS
sugars decreased by various amounts depending on the strain and the
sugar. The generation times of Ga 1.13 increased by a factor of about
1.3 when cells were grown on glucose and fructose, whereas those of Ga
2.45 increased by a factor of 2 on glucose and by a factor of 1.7 on
fructose. The growth of both mutants on the non-PTS sugar galactose was
almost the same, with generation times approximately 1.3-fold longer
than that of the wild-type strain. The growth of the mutants on lactose
was virtually the same, the generation times increasing by less than
1.2 times.
Uptake of 2DG and rate of glucose consumption by resting
cells.
The rate of 2DG transport by the wild type was 1.1 ± 0.1 nmol of 2DG/min/mg (dry weight) of cells, that of Ga 1.13 was
1.4 ± 0.1 nmol of 2DG/min/mg (dry weight) of cells, and that of
Ga 2.45 was 1.4 ± 0.1 nmol of 2DG/min/mg (dry weight) of cells.
The experiments were conducted in duplicate. The results suggested that
a decrease in the amounts of HPr and EI by a factor of at least three
did not reduce the rate at which resting cells took up a
nonmetabolizable PTS sugar. We also determined the rate of glucose
consumption by cells suspended in a phosphate buffer. The values,
expressed as micrograms of glucose consumed per minute per milligram
(dry weight) of cells, were 52 ± 3 for the wild-type strain, 44 ± 4 for Ga 1.13, and 32 ± 1 for Ga 2.45. The experiments were
done in duplicate. These results suggested that a twofold reduction of
EI and/or HPr cellular levels was sufficient to reduce the rate at
which cells metabolize PTS sugars.
Growth in media containing a PTS sugar and a non-PTS sugar.
Growth of the parental strain in media containing glucose or fructose
and either lactose or galactose is diauxic, the PTS sugars being used
before the non-PTS sugars (12, 24). Growing the mutants
under such conditions never resulted in diauxic growth. Growth of Ga
1.13 in the presence of a PTS sugar and a non-PTS sugar gave rise to a
continuous S-shaped growth curve, and both sugars were used at the same
time. This is exemplified by the growth of Ga 1.13 in a mixture of
glucose and galactose (Fig. 4B). The
growth of Ga 2.45 in mixtures of sugars also resulted in a single,
uninterrupted growth phase. However, unlike Ga 1.13, Ga 2.45 always
metabolized sugars sequentially, the non-PTS sugar being used before
the PTS sugar. The growth of Ga 2.45 in a mixture of glucose and
galactose is illustrated in Fig. 4C.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 4.
Growth patterns of the wild-type strain (A), mutant Ga
1.13 (B), and mutant Ga 2.45 (C) when grown in a medium containing
glucose (a PTS sugar) and galactose (a non-PTS sugar). An 0.5-ml
aliquot of glucose-grown cells was transferred into 15 ml of fresh
medium containing approximately 0.1% (wt/vol) glucose and 0.2%
(wt/vol) galactose. The symbols represent the OD660 ( )
and the consumption of glucose ( ) and galactose ( ).
|
|
Activities of
-galactosidase, galactokinase, and
-galactosidase.
The incapacity of the mutants to prevent the
metabolism of non-PTS sugars in the presence of glucose or fructose
prompted us to determine the activities of
-galactosidase,
galactokinase, and
-galactosidase, three inducible enzymes involved
in the metabolism of the non-PTS sugars lactose, galactose, and
melibiose in S. salivarius. The activities of these enzymes
were very low in glucose- and fructose-grown wild-type cells (Table
4) (12, 24). However, we
reproducibly observed that fructose caused a stronger repression of
these enzymes than did glucose, despite the fact that the levels of
HPr(Ser-P) and HPr(His~P) were virtually the same in both fructose- and glucose-grown wild-type cells (Table 2). The enzymes were derepressed in both mutants, but the level of derepression varied according to the enzyme, the growth sugar, and the mutant strain. As a
general rule, we observed that (i) the levels of enzyme activities were
lower in fructose-grown cells than in glucose-grown cells and (ii),
when compared with the parental strain, derepression was stronger in Ga
2.45 than in Ga 1.13.
Galactokinase and
-galactosidase were slightly derepressed in
glucose- and fructose-grown Ga 1.13, but the activities remained very
low and far below the activities measured in fully induced wild-type
cells (Table 4). These enzymes, however, were strongly derepressed in
Ga 2.45, which possessed 10 to 40 times more activity than did
the parental strain after growth on PTS sugars.
Unlike the other enzymes,
-galactosidase was significantly
derepressed in both mutants after growth on glucose and fructose. Derepression was, however, highest in Ga 2.45, as was the case for
-galactosidase and galactokinase. In glucose-grown Ga 2.45, the gene
coding for
-galactosidase was obviously expressed at its maximal
rate, as the level of activity was identical to that in cells grown on
melibiose, the inducing sugar. Interestingly, the enzyme was only
slightly or not at all derepressed in the mutants grown on lactose, a
noninducing non-PTS sugar.
HPr(Ser-P) has been shown to be involved in the control of gene
expression in gram-positive bacteria. Using data reported in Tables 2
and 4, we verified whether there was a correlation between the
magnitude of galactokinase,
-galactosidase, and
-galactokinase derepression and the cellular levels of HPr(Ser-P) measured in the
wild-type and mutant strains after growth on glucose and fructose. As
illustrated in Fig. 5, there was no
correlation between the cellular amounts of HPr(Ser-P) and enzyme
activities. For instance, the levels of HPr(Ser-P) were identical in
fructose-grown cells of Ga 1.13 and in glucose-grown cells of Ga 2.45 (Table 2) while the levels of
-galactosidase were 10-fold lower in
mutant Ga 1.13 (34 ± 1) than in mutant Ga 2.45 (Table
4).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 5.
Galactokinase, -galactosidase, and
-galactosidase activities as a function of cellular levels of
HPr(Ser-P). Cellular levels of HPr(Ser-P) are indicated in Table 2,
while enzyme activities are indicated in Table 4. The values used are
those that have been determined for glucose- and fructose-grown
cells.
|
|
Inducer exclusion by growing cells.
The inability of the
mutants to prevent the metabolism of non-PTS sugars in the presence of
PTS sugars may also result from their incapacity to exert inducer
exclusion. We have previously shown that, when glucose is added to
wild-type S. salivarius cells growing in the presence of
lactose, galactose, or melibiose, the metabolism of the non-PTS sugar
immediately stops and resumes only when the glucose is depleted
(24). In the work presented here, we extended our study by
looking at the effect of fructose on the metabolism of lactose and
galactose. As illustrated in Fig. 6, the addition of fructose to
growing wild-type cells also stopped the metabolism of lactose, which
resumed only when the fructose was exhausted. Similar results were
obtained with cells growing on galactose (data not shown). In contrast,
we observed that the addition of glucose or fructose to growing mutant
cells did not prevent the metabolism of lactose or galactose. The
effect of fructose on the utilization of lactose is illustrated in Fig. 6 as an example. Similar results were
obtained with the other combinations of sugars. All experiments were
done in duplicate, and results were reproducible.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 6.
Effect of fructose on lactose metabolism by growing
cells. Cells were grown overnight in the presence of 0.2% lactose. An
0.5-ml aliquot was used to inoculate 15 ml of fresh medium containing
0.2% (wt/vol) lactose. When the culture reached mid-log phase, the
medium was supplemented with 0.1% (wt/vol) fructose (indicated by the
arrows). The symbols represent the OD660 ( ) and the
consumption of lactose ( ) and that of fructose ( ).
|
|
 |
DISCUSSION |
Thompson and Chassy (37) have already demonstrated
that the toxicity of 2DG in lactococci is caused by the establishment of a futile cycle that leads to the dissipation of phosphoenolpyruvate and ATP. Other studies have reported that nonmetabolizable
phosphorylated sugars are toxic by interfering with gene expression,
permease, or enzyme activities (20, 28, 38, 39). Although
the toxicity of 2DG in S. salivarius has never been
scrutinized, it is reasonable to assume that these mechanisms
contribute to some extent to the toxicity of 2DG in this microorganism,
since this sugar analog is transported in S. salivarius by
the glucose-mannose PTS and accumulates in the cell as a phosphorylated
derivative (40). On the basis of these hypotheses, our
results suggested that decreasing the cellular amounts of HPr and EI by
a factor of two or three or introducing point mutations in HPr
prevented the establishment of a lethal futile energy cycle and
probably restricted the intracellular accumulation of 2DG-phosphate to
nontoxic levels. These mechanisms, however, could not explain why
selection on galactose favored the isolation of ptsH
mutants. Further research is required to explain this enigmatic result.
Selection of mutants on 2DG and galactose has proved, however, to be
useful to identify amino acids that are important for HPr to exert its
functions. Indeed, we have identified 13 amino acids that are essential
for HPr to properly accomplish its physiological functions in S. salivarius. Interestingly, most of these amino acids are well
conserved in gram-positive bacterial HPrs. Ten of these amino acids
were found between positions 16 and 48, suggesting that helix 1, the
loop between helix 1 and
-strand 2, and helix 2 are critical
structural determinants with respect to streptococcal HPr regulatory
functions (Fig. 2). These results are consistent with the proposal that HPr interacts with other PTS proteins and proteins under its control via regions located at its surface comprising
-helices 1 and 2 and
the loops preceding helix 1 and following helix 2 (17, 49,
53) and with the findings of Jones et al. (17), who showed that residues 14 to 17 and 21 to 27 of B. subtilis
HPr are involved in the interaction with the transcriptional regulator CcpA. We also found that residues at positions 69 and 70 (D and A,
respectively) were important for normal streptococcal HPr functions, since the replacement of these amino acids by N and T, respectively, conferred resistance to 2DG. These results are consistent with those
reported by Koch et al. (18), who showed that residues at
these positions in E. coli HPr (D and E) play important
roles in controlling conformational aspects of HPr. It is noteworthy that, despite the large number of clones that we analyzed, we did not
find any HPr mutants with a mutation replacing Ser46.
A significant proportion of the mutants possessed a mutation in the
pts promoter or the 5' UTR located upstream from the
ptsH initiation codon. In all cases, these mutations
resulted in a decrease in the cellular amount of HPr, revealing the
importance of specific nucleotides in the efficiency of the
pts promoter and the essential role of the 5' UTR in the
expression of the pts operon. In mutant Ga 2.45, the second
T of the TTG sequence located at the 5' end of the
35 box of the
pts promoter was replaced by a C, causing a threefold
decrease in cellular amounts of HPr and EI. This demonstrated the
importance of this nucleotide for optimal recognition of the promoter
by the major streptococcal RNA polymerase. This mutation reduced the
levels of HPr and EI to the same extent, a result that is
understandable, as this mutation, by affecting the rate of
transcription, will reduce the expression of all the genes making up
the operon. The results obtained with Ga 1.13, which underwent an
A-to-G transition in the ribosome binding site of ptsH,
were, however, unexpected. Indeed, this type of mutation should affect
only HPr levels, since this DNA signal sequence should not interfere
with the rate of transcription of the operon or with the rate of
translation of ptsI. Surprisingly, we found that the amount
of EI in this mutant was reduced by a factor of two. This may be
explained in terms of a translational coupling between ptsH
and ptsI or by the involvement of HPr in the expression of
ptsI.
The growth of the wild-type strain in media containing a PTS sugar
(glucose or fructose) and a non-PTS sugar (lactose or galactose) is
diauxic, the PTS sugar being metabolized before the non-PTS sugar
(12, 24). The growth of mutants Ga 1.13 and Ga 2.45 under
the same conditions was never diauxic, and both mutants had lost the
ability to metabolize PTS sugars preferentially, indicating that a
twofold decrease in HPr and EI cellular levels was sufficient to
prevent the cells from selectively metabolizing PTS sugars in
preference to non-PTS sugars. Diauxic growth is a manifestation of at
least two physiological processes, inducer exclusion and inhibition of
gene expression. Results reported in this paper indicated that reducing
the cellular levels of the general PTS proteins two- to threefold
interfered with both processes.
A reduction in the synthesis of EI and HPr resulted in a decline in the
levels of the two predominant forms of HPr found in rapidly growing
streptococcal cells, HPr(Ser-P) and HPr(Ser-P)(His~P) (43). This drop could not be attributed to a defect in
HPrK, as no mutation was found in ptsK of Ga 1.13 and Ga
2.45, and both mutants possessed the same levels of HPrK activity as
that of the wild-type strain. Thus, a two- to threefold reduction in
the expression of the pts operon was sufficient to alter the
proportion of the different forms of HPr in the cell. The sharpest
decrease in the amount of the doubly phosphorylated product was
observed in glucose-grown cells of Ga 2.45, which contained less EI
than did mutant Ga 1.13. This result suggested that the low level of HPr(Ser-P)(His~P) observed with Ga 2.45 was the consequence of a
combination of two events: a reduction in the concentration of the
substrate HPr(Ser-P) and a reduction in the amount of EI, the enzyme
that catalyzes the phosphorylation on His15. However, results obtained
with fructose-grown cells of the same mutant were not consistent with
this explanation, as they contained the same amount of EI and almost
the same amount of HPr(Ser-P) as glucose-grown cells but seven times
more HPr(Ser-P)(His~P) (Table 2). The generation times of Ga 2.45 indicated, however, that this mutant grew slower on glucose than on
fructose (Table 3). This difference in growth rate would obviously
modify the levels of several glycolytic and other types of
intermediates in the cells and therefore might influence the activities
of the HPrK and EI. It therefore appears that the amount of
HPr(Ser-P)(His~P) is dictated by several determinants, including the
amounts of HPr and EI and the nature of the sugar that supports growth,
as well as the rate at which the cells divide. As the physiological functions of the doubly phosphorylated product remain to be elucidated for streptococci, it remains unclear whether the physiological defects
observed for the mutants were caused, to some extent, by a decrease in
the cellular amounts of this form of HPr. However, several lines of
evidence have demonstrated that HPr(Ser-P) plays a major role in the
exclusion of non-PTS sugars by PTS sugars in gram-positive bacteria
(7, 31, 48, 50-52). Our results suggested that a twofold
decrease in the levels of HPr(Ser-P) in S. salivarius was
sufficient to prevent growing cells from excluding non-PTS sugars when
a PTS sugar became available. In gram-positive bacteria, HPr(Ser-P) is
also involved in the regulation of gene transcription (6, 8, 13,
17). Results presented in this paper unequivocally indicated
that reducing the synthesis of HPr by a factor of three was enough to
cause a strong derepression of galactokinase,
-galactosidase, and
-galactosidase, three inducible enzymes in S. salivarius.
Our results also suggested that the expression of the genes coding for
these enzymes was controlled by HPr in a hierarchical manner. Indeed, a
twofold reduction of total HPr caused a significant derepression of
-galactosidase, while the synthesis of galactokinase and
-galactosidase was only slightly affected. On the other hand, a
threefold reduction of HPr caused a strong derepression of the three
enzymes. However, we did not find a correlation between the magnitude
of enzyme derepression and the cellular levels of HPr(Ser-P). Moreover, we observed that
-galactosidase, which was strongly derepressed in
both mutants after growth on glucose and fructose, was only slightly or
not at all derepressed in lactose-grown cells. These results are
consistent with those reported for an S. salivarius mutant
in which Ile47 is replaced by Thr (mutant G22.4) (12). The
enzymes
-galactosidase and
-galactosidase are derepressed in this
mutant, even though it possesses cellular levels of HPr(Ser-P) similar
to those found in the wild-type strain. Moreover, derepression of
-galactosidase and
-galactosidase in mutant G22.4 is observed after growth on glucose or fructose, each a PTS sugar, but not after
growth on lactose or galactose, each a non-PTS sugar (12). It thus appears that PTS-mediated repression of catabolic genes in
streptococci involves a complex regulatory circuit in which HPr plays a
dominant role, but not uniquely as HPr(Ser-P), and that genes
under the control of the PTS, such as the melibiose genes, might be
subjected to different regulatory mechanisms depending on whether the
cells grow at the expense of a PTS sugar or a non-PTS sugar.
The mutants took up 2DG at the same rate as that of the parental
strain, suggesting that a threefold reduction of HPr and EI cellular
levels had no effect on the rate of sugar transport by the PTS.
However, the uptake of a nonmetabolizable sugar such as 2DG does not
result in ATP synthesis. Under these conditions, cells do not produce
HPr(Ser-P), and all the HPr is available for sugar transport.
Therefore, the results obtained from the 2DG uptake experiments
suggested that decreasing the amount of EI by a factor of at least
three would not change the transport capacity of the PTS as long as the
amount of HPr available for transport was not limiting. On the other
hand, we observed a decline in the rate of glucose consumption in the
mutants compared with the parental strain, suggesting that when cells
were able to generate HPr(Ser-P), a twofold reduction in HPr and EI
synthesis was sufficient to affect the rate at which a PTS sugar was
metabolized. This may explain to some extent the fact that the
generation times of the mutants on PTS sugars were longer than those of
the wild-type strain. This might not, however, be the only factor that
reduced the growth of the mutants. The observation that some enzymes
were derepressed to different degrees in the mutants (Table 4)
suggested that the increase in generation times observed when they were growing on PTS sugars, and possibly also on non-PTS sugars, resulted from a futile expenditure of energy engendered by the synthesis of
useless proteins.
We have shown in this paper that a two- to threefold reduction of HPr
and EI synthesis is sufficient to modify several aspects of the cell
physiology. A reduction of this magnitude could obviously occur when
growth is reduced due to adverse chemical or physical conditions. For
example, Thevenot et al. (36) have shown that the amount
of total HPr is reduced about 2 times and that of HPr(Ser-P) is reduced
about 15 times in Streptococcus mutans cells cultured at a
dilution rate of 0.1 h
1 (which corresponds to a doubling
time of 7 h) in the presence of 10 mM glucose compared with that
for cells growing at the same rate in the presence of 100 mM glucose.
Considering the fact that oral streptococci live in conditions of
starvation and slow growth for long periods (3), it is
reasonable to assume that in their natural habitat these bacteria
contain reduced amounts of HPr, enabling them to take up PTS and
non-PTS sugars nonpreferentially.
This research was supported by the Medical Research Council of
Canada operating grants MT 6979 and MOP 36338.
| 1.
|
Avigad, G.,
D. Amaval,
C. Ascensio, and B. L. Horecker.
1962.
The D-galactose oxydase of Polyporus circinatus.
J. Biol. Chem.
237:2736-2743[Free Full Text].
|
| 2.
|
Brochu, D., and C. Vadeboncoeur.
1999.
The HPr(Ser) kinase of Streptococcus salivarius: purification, properties, and cloning of the hprK gene.
J. Bacteriol.
181:709-717[Abstract/Free Full Text].
|
| 3.
|
Burne, R. A.
1998.
Oral streptococci ... products of their environment.
J. Dent. Res.
77:445-452[Abstract/Free Full Text].
|
| 4.
|
Charrier, V.,
E. Buckley,
D. Parsonage,
A. Galinier,
E. Darbon,
M. Jaquinod,
E. Forest,
J. Deutscher, and A. Claiborne.
1997.
Cloning and sequencing of two enterococcal glpK genes and regulation of the encoded glycerol kinases by phosphoenolpyruvate-dependent, phosphotransferase system-catalyzed phosphorylation of a single histidyl residue.
J. Biol. Chem.
272:14166-14174[Abstract/Free Full Text].
|
| 5.
|
Deutscher, J.,
B. Bauer, and H. Sauerwald.
1993.
Regulation of glycerol metabolism in Enterococcus faecalis by phosphoenolpyruvate-dependent phosphorylation of glycerol kinase catalyzed by enzyme I and HPr of the phosphotransferase system.
J. Bacteriol.
175:3730-3733[Abstract/Free Full Text].
|
| 6.
|
Deutscher, J.,
E. Küster,
U. Bergstedt,
V. Charrier, and W. Hillen.
1995.
Protein kinase-dependent HPr/CcpA interaction links glycolytic activity to carbon catabolite repression in Gram-positive bacteria.
Mol. Microbiol.
15:1049-1053[Medline].
|
| 7.
|
Dossonnet, V.,
V. Monedero,
M. Zagorec,
A. Galinier,
G. Pérez-Martinez, and J. Deutscher.
2000.
Phosphorylation of HPr by the bifunctional HPr kinase/P-Ser-HPr phosphatase from Lactobacillus casei controls catabolite repression and inducer exclusion but not inducer expulsion.
J. Bacteriol.
182:2582-2590[Abstract/Free Full Text].
|
| 8.
|
Fujita, Y.,
Y. Miwa,
A. Galinier, and J. Deutscher.
1995.
Specific recognition of the Bacillus subtilis gnt cis-acting catabolite-responsive element by a protein complex formed between CcpA and seryl-phosphorylated HPr.
Mol. Microbiol.
17:953-960[CrossRef][Medline].
|
| 9.
|
Gagnon, G.,
C. Vadeboncoeur, and M. Frenette.
1995.
Regulation of the ptsH and ptsI gene expression in Streptococcus salivarius ATCC 25975.
Mol. Microbiol.
16:1111-1121[CrossRef][Medline].
|
| 10.
|
Gauthier, L.,
S. Bourassa,
D. Brochu, and C. Vadeboncoeur.
1990.
Control of sugar utilization in oral streptococci. Properties of phenotypically distinct 2-deoxyglucose-resistant mutants of Streptococcus salivarius.
Oral Microbiol. Immunol.
5:352-359[Medline].
|
| 11.
|
Gauthier, L.,
S. Thomas,
G. Gagnon,
M. Frenette,
L. Trahan, and C. Vadeboncoeur.
1994.
Positive selection for resistance to 2-deoxyglucose gives rise, in streptococcus salivarius, to seven classes of pleiotropic mutants, including ptsH and ptsI missense mutants.
Mol. Microbiol.
13:1101-1109[CrossRef][Medline].
|
| 12.
|
Gauthier, M.,
D. Brochu,
L. D. Eltis,
S. Thomas, and C. Vadeboncoeur.
1997.
Replacement of isoleucine-47 by threonine in the HPr protein of Streptococcus salivarius abrogates the preferential metabolism of glucose and fructose over lactose and melibiose but does not prevent the phosphorylation of HPr on serine-46.
Mol. Microbiol.
25:695-705[CrossRef][Medline].
|
| 13.
|
Gösseringer, R.,
L. Küster,
A. Galinier,
J. Deutscher, and W. Hillen.
1997.
Cooperative and non-cooperative DNA binding modes of catabolite control protein CcpA from Bacillus megaterium result from sensing two different signals.
J. Mol. Biol.
266:665-676[CrossRef][Medline].
|
| 14.
|
Gunnewijk, M. G. W., and B. Poolman.
2000.
Phosphorylation state of HPr determines the level of expression and the extent of phosphorylation of the lactose transport protein of Streptococcus thermophilus.
J. Biol. Chem.
245:34073-34079.
|
| 15.
|
Hamilton, I. R., and G. C. Y. Lo.
1978.
Co-induction of -galactosidase and the lactose-P-enolpyruvate phosphotransferase system in Streptococcus salivarius and Streptococcus mutans.
J. Bacteriol.
136:900-908[Abstract/Free Full Text].
|
| 16.
|
Hueck, C. J.,
W. Hillen, and M. H. Saier, Jr.
1994.
Analysis of a cis-active sequence mediating catabolite repression in Gram-positive bacteria.
Res. Microbiol.
145:503-518[Medline].
|
| 17.
|
Jones, B. E.,
V. Dossonnet,
E. Küster,
W. Hillen,
J. Deutscher, and R. E. Klevit.
1997.
Binding of the catabolite repressor protein CcpA to its DNA target is regulated by phosphorylation of its corepressor HPr.
J. Biol. Chem.
272:26530-26535[Abstract/Free Full Text].
|
| 18.
|
Koch, S.,
S. L. Sutrina,
L. F. Wu,
J. Reizer,
K. Schnetz,
B. Rak, and M. H. Saier, Jr.
1996.
Identification of a site in the phosphocarrier protein, HPr, which influences its interactions with sugar permeases of the bacterial phosphotransferase system: kinetic analyses employing site-specific mutants.
J. Bacteriol.
178:1126-1133[Abstract/Free Full Text].
|
| 19.
|
Kundig, W.,
S. Ghosh, and S. Roseman.
1964.
Phosphate bound histidine in a protein as an intermediate in a novel phospho-transferase system.
Proc. Natl. Acad. Sci. USA
52:1067-1074[Free Full Text].
|
| 20.
|
London, J., and S. Hausman.
1982.
A study of the xylitol-mediated transient inhibition of ribitol utilization by Lactobacillus casei.
J. Bacteriol.
150:657-661[Abstract/Free Full Text].
|
| 21.
|
Lortie, L. A.,
J. D. Dubreuil, and J. Harel.
1991.
Characterization of Escherichia coli strains producing heat-stable enterotoxin b (STb) isolated from humans with diarrhea.
J. Clin. Microbiol.
29:656-659[Abstract/Free Full Text].
|
| 22.
|
McCleary, B. V.
1988.
-Galactosidase from luciferine and guar seed.
Methods Enzymol.
160:627-632.
|
| 23.
|
Peterson, G. L.
1983.
Determination of total protein.
Methods Enzymol.
91:95-119[Medline].
|
| 24.
|
Plamondon, P.,
D. Brochu,
S. Thomas,
J. Fradette,
L. Gauthier,
K. Vaillancourt,
N. Buckley,
M. Frenette, and C. Vadeboncoeur.
1999.
Phenotypic consequences resulting from a methionine-to-valine substitution at position 48 in the HPr protein of Streptococcus salivarius.
J. Bacteriol.
181:6914-6921[Abstract/Free Full Text].
|
| 25.
|
Poolman, B.,
J. Knol,
B. Mollet,
B. Nieuwenhuis, and G. Sulter.
1995.
Regulation of bacterial sugar-H+ symport by phosphoenolpyruvate-dependent enzyme I/HPr-mediated phosphorylation.
Proc. Natl. Acad. Sci. USA
92:778-782[Abstract/Free Full Text].
|
| 26.
|
Poolman, B.,
J. Knol,
C. van der Does,
P. J. F. Henderson,
W. J. Liang,
G. Leblanc,
T. Pourcher, and I. Mus-Veteau.
1996.
Cation and sugar selectivity determinants in a novel family of transport proteins.
Mol. Microbiol.
19:911-922[CrossRef][Medline].
|
| 27.
|
Postma, P. W.,
J. W. Lengeler, and G. R. Jacobson.
1993.
Phosphoenolpyruvate:carbohydrate phosphotransferase systems of bacteria.
Microbiol. Rev.
57:543-594[Abstract/Free Full Text].
|
| 28.
|
Reiner, A. M.
1977.
Xylitol and D-arabitol toxicities due to derepressed fructose, galactitol, and sorbitol phosphotransferases of Escherichia coli.
J. Bacteriol.
132:166-173[Abstract/Free Full Text].
|
| 29.
|
Robitaille, D.,
L. Gauthier, and C. Vadeboncoeur.
1991.
The presence of two forms of the phosphocarrier protein HPr of the phosphoenolpyruvate:sugar phosphotransferase system in streptococci.
Biochimie
73:573-581[Medline].
|
| 30.
|
Roe, J. H.
1934.
A colorimetric method for the determination of fructose in blood and urine.
J. Biol. Chem.
107:15-22[Free Full Text].
|
| 31.
|
Saier, M. H., Jr.,
S. Chauvaux,
G. M. Cook,
J. Deutscher,
I. T. Paulsen,
J. Reizer, and J. J. Ye.
1996.
Catabolite repression and inducer control in Gram-positive bacteria.
Microbiology
142:217-230[Abstract].
|
| 32.
|
Saier, M. H., Jr., and J. Reizer.
1992.
Proposed uniform nomenclature for the proteins and protein domains of the bacterial phosphoenolpyruvate:sugar phosphotransferase system.
J. Bacteriol.
174:1433-1438[Free Full Text].
|
| 33.
|
Saier, M. H., Jr., and J. Reizer.
1994.
The bacterial phosphotransferase system: new frontiers 30 years later.
Mol. Microbiol.
13:755-764[Medline].
|
| 34.
|
Stülke, J.,
M. Arnaud,
G. Rapoport, and I. Martin-Verstraete.
1998.
PRD a protein domain involved in PTS-dependent induction and carbon catabolite repression of catabolic operons in bacteria.
Mol. Microbiol.
28:865-874[CrossRef][Medline].
|
| 35.
|
Stülke, J., and W. Hillen.
2000.
Regulation of carbon catabolism in Bacillus species.
Annu. Rev. Microbiol.
54:849-880[CrossRef][Medline].
|
| 36.
|
Thevenot, T.,
D. Brochu,
C. Vadeboncoeur, and I. R. Hamilton.
1995.
Regulation of ATP-dependent P-(Ser)-HPr formation in Streptococcus mutans and Streptococcus salivarius.
J. Bacteriol.
177:2751-2759[Abstract/Free Full Text].
|
| 37.
|
Thompson, J., and B. M. Chassy.
1982.
Novel phosphoenolpyruvate-dependent futile cycle in Streptococcus lactis: 2-deoxy-D-glucose uncouples energy production from growth.
J. Bacteriol.
151:1454-1465[Abstract/Free Full Text].
|
| 38.
|
Thompson, J., and B. M. Chassy.
1983.
Regulation of glycolysis and sugar phosphotransferase activities in Streptococcus lactis: growth in the presence of 2-deoxy-D-glucose.
J. Bacteriol.
154:819-830[Abstract/Free Full Text].
|
| 39.
|
Trahan, L.
1995.
Xylitol: a review of its action on mutants streptococci and dental plaque its clinical significance.
Int. Dent. J.
45:77-92[Medline].
|
| 40.
|
Vadeboncoeur, C.
1984.
Structure and properties of the phosphoenolpyruvate:glucose phosphotransferase system of oral streptococci.
Can. J. Microbiol.
30:495-502[Medline].
|
| 41.
|
Vadeboncoeur, C.
1995.
HPr: heteromorphous protein.
Res. Microbiol.
146:525-530[Medline].
|
| 42.
|
Vadeboncoeur, C.,
G. Bourgeau,
D. Mayrand, and L. Trahan.
1983.
Control of sugar utilization in the oral bacteria Streptococcus salivarius and Streptococcus sanguis by the phosphoenolpyruvate:glucose phosphotransferase system.
Arch. Oral Biol.
28:123-131[CrossRef][Medline].
|
| 43.
|
Vadeboncoeur, C.,
D. Brochu, and J. Reizer.
1991.
Quantitative determination of the intracellular concentration of the various forms of HPr, a phosphocarrier protein of the phosphoenolpyruvate:sugar phosphotransferase system in growing cells of oral streptococci.
Anal. Biochem.
196:24-30[CrossRef][Medline].
|
| 44.
|
Vadeboncoeur, C.,
M. Frenette, and L. A. Lortie.
2000.
Regulation of the pts operon in low G+C Gram-positive bacteria.
J. Mol. Microbiol. Biotechnol.
2:483-490[Medline].
|
| 45.
|
Vadeboncoeur, C., and M. Pelletier.
1997.
The phosphoenolpyruvate:sugar phosphotransferase system of oral streptococci and its role in the control of sugar metabolism.
FEMS Microbiol. Rev.
19:187-207[CrossRef][Medline].
|
| 46.
|
Vadeboncoeur, C., and L. Trahan.
1982.
Glucose transport in Streptococcus salivarius. Evidence for the presence of a distinct phosphoenolpyruvate:glucose phosphotransferase system which catalyses the phosphorylation of -methyl glucoside.
Can. J. Microbiol.
28:190-199[Medline].
|
| 47.
|
Vaughan, E. E.,
S. David, and W. M. de Vos.
1996.
The lactose transporter in Leuconostoc lactis is a new member of the LacS subfamily of galactoside-pentose-hexuronide translocators.
Appl. Environ. Microbiol.
62:1574-1582[Abstract].
|
| 48.
|
Viana, R.,
V. Monedero,
V. Dossonnet,
C. Vadeboncoeur,
G. Pérez-Martinez, and J. Deutscher.
2000.
Enzyme I and HPr from Lactobacillus casei: their role in sugar transport, carbon catabolite repression and inducer exclusion.
Mol. Microbiol.
36:570-584[CrossRef][Medline].
|
| 49.
|
Wang, G.,
M. Sondej,
D. S. Garrett,
A. Peterkofsky, and M. G. Clore.
2000.
A common interface on HPr for interaction with its partner proteins.
J. Biol. Chem.
275:16401-16403[Abstract/Free Full Text].
|
| 50.
|
Ye, J. J.,
J. Minarcik, and M. H. Saier, Jr.
1996.
Inducer expulsion and the occurrence of an HPr(Ser-P)-activated sugar-phosphate phosphatase in Enterococcus faecalis and Streptococcus pyogenes.
Microbiology
142:585-592[Abstract].
|
| 51.
|
Ye, J. J.,
J. Reizer,
X. Cui, and M. H. Saier, Jr.
1994.
ATP-dependent phosphorylation of serine-46 in the phosphocarrier protein HPr regulated lactose/H+ symport in Lactobacillus brevis.
Proc. Natl. Acad. Sci. USA
91:3102-3106[Abstract/Free Full Text].
|
| 52.
|
Ye, J. J.,
J. Reizer,
X. Cui, and M. H. Saier, Jr.
1994.
Inhibition of the phosphoenolpyruvate:lactose phosphotransferase system and activation of a cytoplasmic sugar-phosphate phosphatase in Lactococcus lactis by ATP-dependent metabolite-activated phosphorylation of serine 46 in the phosphocarrier protein HPr.
J. Biol. Chem.
269:11837-11844[Abstract/Free Full Text].
|
| 53.
|
Zhu, P. P.,
O. Herzberg, and A. Peterkofsky.
1998.
Topography of the interaction of HPr(Ser) kinase with HPr.
Biochemistry
37:11762-11770[CrossRef][Medline].
|